Amgen Inc.
VARIANTS OF TISSUE INHIBITOR OF METALLOPROTEINASE TYPE THREE (TIMP-3), COMPOSITIONS AND METHODS

Last updated:

Abstract:

There are disclosed TIMP-3 muteins, variants and derivatives, nucleic acids encoding them, and methods of making and using them.

Status:
Application
Type:

Utility

Filling date:

1 Oct 2021

Issue date:

24 Mar 2022